OrthoPediatrics (NASDAQ:KIDS) Stock Rating Upgraded by Wall Street Zen

Key Points

• OrthoPediatrics has been upgraded from a "sell" to a "hold" rating by Wall Street Zen, indicating a shift in analyst sentiment regarding the stock's performance.
• Analysts have varying target prices for OrthoPediatrics, with JMP Securities setting a target of $35.00, while Needham & Company LLC has a higher target of $42.00.
• The company's stock has had a 1.5% decrease, trading at around $18.91, with analysts expecting a loss of -0.93 EPS for the current year.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.

KIDS has been the topic of several other research reports. Truist Financial cut their price objective on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. BTIG Research dropped their price target on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating on the stock in a research report on Wednesday, August 6th. JMP Securities set a $35.00 price target on OrthoPediatrics and gave the stock a "market outperform" rating in a research report on Friday, August 8th. Needham & Company LLC reissued a "buy" rating and set a $42.00 price target on shares of OrthoPediatrics in a research report on Thursday, May 8th. Finally, Citigroup restated a "market outperform" rating on shares of OrthoPediatrics in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $34.14.

OrthoPediatrics Trading Up 3.1%

OrthoPediatrics stock traded up $0.61 during mid-day trading on Friday, hitting $20.22. The company's stock had a trading volume of 20,420 shares, compared to its average volume of 199,501. The company has a 50 day moving average of $21.34 and a 200-day moving average of $22.50. The stock has a market cap of $507.00 million, a PE ratio of -11.30 and a beta of 1.12. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66. OrthoPediatrics has a one year low of $16.59 and a one year high of $33.14.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.06. The company had revenue of $61.08 million for the quarter, compared to the consensus estimate of $61.40 million. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%. On average, research analysts anticipate that OrthoPediatrics will post -0.93 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KIDS. Millennium Management LLC purchased a new stake in OrthoPediatrics in the fourth quarter valued at about $9,798,000. Point72 Asset Management L.P. acquired a new stake in shares of OrthoPediatrics during the fourth quarter worth about $7,450,000. Wasatch Advisors LP lifted its holdings in shares of OrthoPediatrics by 47.2% during the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company's stock worth $16,141,000 after purchasing an additional 223,217 shares during the period. Harbor Capital Advisors Inc. lifted its holdings in shares of OrthoPediatrics by 116.5% during the second quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company's stock worth $7,173,000 after purchasing an additional 179,733 shares during the period. Finally, Wellington Management Group LLP lifted its holdings in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock worth $24,601,000 after purchasing an additional 178,078 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.